☰

Tanya Stoyanova, Ph.D. - Publications

Affiliations: 
2009 University of Illinois at Chicago, Chicago, IL, United States 
Area:
Biochemistry
Tree Info Similar researchers PubMed Report error

29 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Hsu EC, Shen M, Aslan M, Liu S, Kumar M, Garcia-Marques F, Nguyen HM, Nolley R, Pitteri SJ, Corey E, Brooks JD, Stoyanova T. MCM2-7 complex is a novel druggable target for neuroendocrine prostate cancer. Scientific Reports. 11: 13305. PMID 34172788 DOI: 10.1038/s41598-021-92552-x  0.31
2020 Hsu EC, Rice MA, Bermudez A, Marques FJG, Aslan M, Liu S, Ghoochani A, Zhang CA, Chen YS, Zlitni A, Kumar S, Nolley R, Habte F, Shen M, Koul K, ... ... Stoyanova T, et al. Trop2 is a driver of metastatic prostate cancer with neuroendocrine phenotype via PARP1. Proceedings of the National Academy of Sciences of the United States of America. PMID 31932422 DOI: 10.1073/Pnas.1905384117  0.369
2019 Rice MA, Hsu EC, Aslan M, Ghoochani A, Su A, Stoyanova T. Loss of Notch1 activity inhibits prostate cancer growth and metastasis and sensitizes prostate cancer cells to anti-androgen therapies. Molecular Cancer Therapeutics. PMID 31028097 DOI: 10.1158/1535-7163.Mct-18-0804  0.375
2018 Going CC, Tailor D, Kumar V, Birk AM, Pandrala M, Rice MA, Stoyanova T, Malhotra S, Pitteri SJ. Quantitative proteomic profiling reveals key pathways in the anti-cancer action of methoxychalcone derivatives in triple negative breast cancer. Journal of Proteome Research. PMID 30200768 DOI: 10.1021/Acs.Jproteome.8B00636  0.317
2018 Xie J, Rice M, Cheng Y, Song G, Kunder C, Brooks JD, Stoyanova T, Rao J. Abstract B068: Methionine aminopeptidase II (MetAP2) activated in situ self-assembly of small-molecule probes for imaging prostate cancer Cancer Research. 78. DOI: 10.1158/1538-7445.Prca2017-B068  0.332
2017 Roy N, Stoyanova T, Dominguez-Brauer C, Park HJ, Bagchi S, Raychaudhuri P. Retraction for Roy et al., "DDB2, an Essential Mediator of Premature Senescence". Molecular and Cellular Biology. 37. PMID 28512213 DOI: 10.1128/Mcb.00135-17  0.6
2017 Rice MA, Hsu E, Stoyanova T. Abstract 4917: Therapeutic inhibition of Notch1 in metastatic prostate cancer Cancer Research. 77: 4917-4917. DOI: 10.1158/1538-7445.Am2017-4917  0.374
2016 Liu X, Grogan TR, Hieronymus H, Hashimoto T, Mottahedeh J, Cheng D, Zhang L, Huang K, Stoyanova T, Park JW, Shkhyan RO, Nowroozizadeh B, Rettig MB, Sawyers CL, Elashoff D, et al. Low CD38 Identifies Progenitor-like Inflammation-Associated Luminal Cells that Can Initiate Human Prostate Cancer and Predict Poor Outcome. Cell Reports. 17: 2596-2606. PMID 27926864 DOI: 10.1016/J.Celrep.2016.11.010  0.35
2016 Stoyanova T, Riedinger M, Lin S, Faltermeier CM, Smith BA, Zhang KX, Going CC, Goldstein AS, Lee JK, Drake JM, Rice MA, Hsu EC, Nowroozizadeh B, Castor B, Orellana SY, et al. Activation of Notch1 synergizes with multiple pathways in promoting castration-resistant prostate cancer. Proceedings of the National Academy of Sciences of the United States of America. PMID 27694579 DOI: 10.1073/Pnas.1614529113  0.364
2016 Ju X, Jiao X, Ertel A, Casimiro MC, Di Sante G, Deng S, Li Z, Di Rocco A, Zhan T, Hawkins A, Stoyanova T, Ando S, Fatatis A, Lisanti MP, Gomella LG, et al. SRC ONCOGENE INDUCES TROP2 PROTEOLYTIC ACTIVATION VIA CYCLIN D1. Cancer Research. PMID 27634768 DOI: 10.1158/0008-5472.Can-15-3327  0.366
2016 Drake JM, Paull EO, Graham NA, Lee JK, Smith BA, Titz B, Stoyanova T, Faltermeier CM, Uzunangelov V, Carlin DE, Fleming DT, Wong CK, Newton Y, Sudha S, Vashisht AA, et al. Phosphoproteome Integration Reveals Patient-Specific Networks in Prostate Cancer. Cell. PMID 27499020 DOI: 10.1016/J.Cell.2016.07.007  0.359
2016 Lee JK, Phillips JW, Smith BA, Park JW, Stoyanova T, McCaffrey EF, Baertsch R, Sokolov A, Meyerowitz JG, Mathis C, Cheng D, Stuart JM, Shokat KM, Gustafson WC, Huang J, et al. N-Myc Drives Neuroendocrine Prostate Cancer Initiated from Human Prostate Epithelial Cells. Cancer Cell. 29: 536-47. PMID 27050099 DOI: 10.1016/J.Ccell.2016.03.001  0.334
2016 Drake JM, Paull EO, Graham NA, Lee JK, Smith BA, Stoyanova T, Faltermeier CM, Carlin DE, Vashisht A, Huang J, Wohlschlegel JA, Graeber TG, Witte ON, Stuart JM. Abstract 3882: Patient-specific druggable networks in lethal prostate cancer through proteome-guided multi-omic integration Cancer Research. 76: 3882-3882. DOI: 10.1158/1538-7445.Am2016-3882  0.364
2015 Miyahira AK, Lang JM, Den RB, Garraway IP, Lotan TL, Ross AE, Stoyanova T, Cho SY, Simons JW, Pienta KJ, Soule HR. Multidisciplinary intervention of early, lethal metastatic prostate cancer: Report from the 2015 Coffey-Holden Prostate Cancer Academy Meeting. The Prostate. PMID 26477609 DOI: 10.1002/Pros.23107  0.341
2015 Stoyanova T, Faltermeier C, Smith B, Goldstein A, Zhang X, Drake J, Lee J, Orellana S, Blum S, Cheng D, Pienta K, Huang J, Witte O. Abstract 4985: Notch1 as a key mediator in promoting advanced castration-resistant prostate cancer Cancer Research. 75: 4985-4985. DOI: 10.1158/1538-7445.Am2015-4985  0.363
2014 Stoyanova T, Goldstein AS. Distinct phases of human prostate cancer initiation and progression can be driven by different cell-types. Cancer Cell & Microenvironment. 1. PMID 26005704 DOI: 10.14800/Ccm.90  0.388
2013 Stoyanova T, Cooper AR, Drake JM, Liu X, Armstrong AJ, Pienta KJ, Zhang H, Kohn DB, Huang J, Witte ON, Goldstein AS. Prostate cancer originating in basal cells progresses to adenocarcinoma propagated by luminal-like cells. Proceedings of the National Academy of Sciences of the United States of America. 110: 20111-6. PMID 24282295 DOI: 10.1073/Pnas.1320565110  0.369
2013 Drake JM, Graham NA, Lee JK, Stoyanova T, Faltermeier CM, Sud S, Titz B, Huang J, Pienta KJ, Graeber TG, Witte ON. Metastatic castration-resistant prostate cancer reveals intrapatient similarity and interpatient heterogeneity of therapeutic kinase targets. Proceedings of the National Academy of Sciences of the United States of America. 110: E4762-9. PMID 24248375 DOI: 10.1073/Pnas.1319948110  0.335
2012 Stoyanova T, Goldstein AS, Cai H, Drake JM, Huang J, Witte ON. Regulated proteolysis of Trop2 drives epithelial hyperplasia and stem cell self-renewal via β-catenin signaling. Genes & Development. 26: 2271-85. PMID 23070813 DOI: 10.1101/Gad.196451.112  0.343
2012 Cai H, Memarzadeh S, Stoyanova T, Beharry Z, Kraft AS, Witte ON. Collaboration of Kras and androgen receptor signaling stimulates EZH2 expression and tumor-propagating cells in prostate cancer. Cancer Research. 72: 4672-81. PMID 22805308 DOI: 10.1158/0008-5472.Can-12-0228  0.382
2012 Drake JM, Graham NA, Stoyanova T, Sedghi A, Goldstein AS, Cai H, Smith DA, Zhang H, Komisopoulou E, Huang J, Graeber TG, Witte ON. Oncogene-specific activation of tyrosine kinase networks during prostate cancer progression. Proceedings of the National Academy of Sciences of the United States of America. 109: 1643-8. PMID 22307624 DOI: 10.1073/Pnas.1120985109  0.324
2012 Stoyanova T, Roy N, Bhattacharjee S, Kopanja D, Valli T, Bagchi S, Raychaudhuri P. p21 cooperates with DDB2 protein in suppression of ultraviolet ray-induced skin malignancies. The Journal of Biological Chemistry. 287: 3019-28. PMID 22167187 DOI: 10.1074/Jbc.M111.295816  0.665
2011 Kopanja D, Roy N, Stoyanova T, Hess RA, Bagchi S, Raychaudhuri P. Cul4A is essential for spermatogenesis and male fertility. Developmental Biology. 352: 278-87. PMID 21291880 DOI: 10.1016/J.Ydbio.2011.01.028  0.647
2010 Goldstein AS, Stoyanova T, Witte ON. Primitive origins of prostate cancer: in vivo evidence for prostate-regenerating cells and prostate cancer-initiating cells. Molecular Oncology. 4: 385-96. PMID 20688584 DOI: 10.1016/J.Molonc.2010.06.009  0.37
2010 Roy N, Stoyanova T, Dominguez-Brauer C, Park HJ, Bagchi S, Raychaudhuri P. DDB2, an essential mediator of premature senescence. Molecular and Cellular Biology. 30: 2681-92. PMID 20351176 DOI: 10.1128/Mcb.01480-09  0.668
2009 Stoyanova T, Roy N, Kopanja D, Raychaudhuri P, Bagchi S. DDB2 (damaged-DNA binding protein 2) in nucleotide excision repair and DNA damage response. Cell Cycle (Georgetown, Tex.). 8: 4067-71. PMID 19923893 DOI: 10.4161/Cc.8.24.10109  0.656
2009 Stoyanova T, Roy N, Kopanja D, Bagchi S, Raychaudhuri P. DDB2 decides cell fate following DNA damage. Proceedings of the National Academy of Sciences of the United States of America. 106: 10690-5. PMID 19541625 DOI: 10.1073/Pnas.0812254106  0.688
2009 Kopanja D, Stoyanova T, Okur MN, Huang E, Bagchi S, Raychaudhuri P. Proliferation defects and genome instability in cells lacking Cul4A. Oncogene. 28: 2456-65. PMID 19430492 DOI: 10.1038/Onc.2009.86  0.6
2008 Stoyanova T, Yoon T, Kopanja D, Mokyr MB, Raychaudhuri P. The xeroderma pigmentosum group E gene product DDB2 activates nucleotide excision repair by regulating the level of p21Waf1/Cip1. Molecular and Cellular Biology. 28: 177-87. PMID 17967871 DOI: 10.1128/Mcb.00880-07  0.593
Show low-probability matches.